Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul;292(1):136-145.
doi: 10.1111/joim.13466. Epub 2022 Mar 7.

Is acid suppression associated with the increased length of stay in diabetic ketoacidosis patients? A nationwide analysis

Affiliations

Is acid suppression associated with the increased length of stay in diabetic ketoacidosis patients? A nationwide analysis

Umer Farooq et al. J Intern Med. 2022 Jul.

Abstract

Background: Diabetic ketoacidosis (DKA) patients present with low serum bicarbonate ( HCO3-${\rm{HCO}}_{3}^{-} $ ), and an increase in its level to ≥15 mEq/L is considered one of the criteria for DKA resolution. Both proton pump inhibitors and histamine-2 receptor antagonists inhibit downstream functioning of H+ /K+ ATPase in the gastric parietal cells, which results in the decreased secretion of HCO3-${\rm{HCO}}_{3}^{-} $ into the bloodstream.

Objectives: We aimed to introduce the hypothesis that DKA patients on acid-suppressive medications may have a delayed rise in serum HCO3-${\rm{HCO}}_{3}^{-} $ to >15 mEq/L that may cause increased hospital length of stay (LOS) and sought to compare the outcomes of such patients. For the sake of simplicity, conditions requiring acid suppression are grouped under the term peptic ulcer disease (PUD) in this study.

Methods: This is a retrospective study using Nationwide Inpatient Sample employing International Classification of Diseases (ICD-10) codes for adult patients with a primary diagnosis of DKA. Analyses were performed using STATA, proportions were compared using Fisher exact test, and continuous variables using Student's t-test. Confounding variables were adjusted using propensity matching, multivariate logistic, and linear regression analyses.

Results: DKA patients with PUD had higher adjusted LOS, intensive care unit admission, and total hospital costs. Mortality and morbidity indicators were similar in both groups. The variables found to be independent predictors of increased LOS were malnutrition, Clostridium difficile infection, pneumonia, Glasgow Coma Scale score of 3-8, and higher Charlson comorbidity score.

Conclusion: We found that Clostridium difficile and pneumonia predicted longer LOS in DKA patients with concomitant PUD, hinting at the possible role of acid suppression in prolonging the LOS in such patients. However, further studies are needed to examine the effect of lesser HCO3-${\rm{HCO}}_{3}^{-} $ generation on LOS.

Keywords: histamine H2 blockers; hospital costs; length of stay; morbidity; mortality; proton pump Inhibitors.

PubMed Disclaimer

Conflict of interest statement

None of the authors has any financial, industrial, or commercial conflict of interest to disclose.

Figures

Fig. 1
Fig. 1
Patient selection flow diagram (DKA, diabetic ketoacidosis; PUD, peptic ulcer disease).

Similar articles

Cited by

References

    1. Wuerth BA, Rockey DC. Changing epidemiology of upper gastrointestinal hemorrhage in the last decade: a nationwide analysis. Dig Dis Sci. 2018;63(5):1286–93. - PubMed
    1. Boonpongmanee S, Fleischer DE, Pezzullo JC, Collier K, Mayoral W, Al‐Kawas F, et al. The frequency of peptic ulcer as a cause of upper‐GI bleeding is exaggerated. Gastrointest Endosc. 2004;59(7):788–94. - PubMed
    1. Ahmed Ullah Mishuk LC, Gaillard P, Westrick S, Hansen RA, Qian J. National trends in prescription proton pump inhibitor use and expenditure in the United States in 2002–2017. J Am Pharm Assoc. 2021;61(1):87–94.E7. - PubMed
    1. Kitabchi AE, Umpierrez GE, Murphy MB, Barrett EJ, Kreisberg RA, Malone JI, et al. Management of hyperglycemic crises in patients with diabetes. Diabet Care. 2001;24(1):131–53. - PubMed
    1. Mendez Y, Surani S, Varon J. Diabetic ketoacidosis: treatment in the intensive care unit or general medical/surgical ward? World J Diabet. 2017;8(2):40–4. - PMC - PubMed